This receptor can be overexpressed in some cancers and studies have proven the importance of HER3 in malignancies such as melanoma, breast, lung, prostate, ovarian and colorectal cancers (Amin et al., 2010; Ma et al., 2014; Zhang et al., 2015). The gene discussed is ERBB3; the disease is cancer.